These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 27242800)
21. Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice. Liu Q; Xue C; Zheng J; Liu K; Wang Y; Wei Y; Liu GD; Cao Y Vaccine; 2015 Jul; 33(32):4035-40. PubMed ID: 26100927 [TBL] [Abstract][Full Text] [Related]
22. Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations. Furuya Y; Regner M; Lobigs M; Koskinen A; Müllbacher A; Alsharifi M J Gen Virol; 2010 Jun; 91(Pt 6):1450-60. PubMed ID: 20147516 [TBL] [Abstract][Full Text] [Related]
26. Development of cross-protective influenza a vaccines based on cellular responses. Soema PC; van Riet E; Kersten G; Amorij JP Front Immunol; 2015; 6():237. PubMed ID: 26029218 [TBL] [Abstract][Full Text] [Related]
27. Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine. Clemens EB; van de Sandt C; Wong SS; Wakim LM; Valkenburg SA Vaccines (Basel); 2018 Mar; 6(2):. PubMed ID: 29587436 [TBL] [Abstract][Full Text] [Related]
28. [Heterosubtypic immunity to influenza A viruses: epidemiological data, involvement of different immunological factors, vaccination]. Naĭkhin AN Vopr Virusol; 2012; 57(3):4-9. PubMed ID: 22905419 [TBL] [Abstract][Full Text] [Related]
29. Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus. Vander Veen RL; Mogler MA; Russell BJ; Loynachan AT; Harris DL; Kamrud KI Vet Rec; 2013 Oct; 173(14):344. PubMed ID: 24078226 [TBL] [Abstract][Full Text] [Related]
30. Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control. Bolton KJ; McCaw JM; Brown L; Jackson D; Kedzierska K; McVernon J PLoS One; 2015; 10(3):e0120138. PubMed ID: 25811654 [TBL] [Abstract][Full Text] [Related]
31. Universal immunity to influenza must outwit immune evasion. Quiñones-Parra S; Loh L; Brown LE; Kedzierska K; Valkenburg SA Front Microbiol; 2014; 5():285. PubMed ID: 24971078 [TBL] [Abstract][Full Text] [Related]
33. Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic. Lo CY; Strobl SL; Dunham K; Wang W; Stewart L; Misplon JA; Garcia M; Gao J; Ozawa T; Price GE; Navidad J; Gradus S; Bhattacharyya S; Viboud C; Eichelberger MC; Weiss CD; Gorski J; Epstein SL Open Forum Infect Dis; 2017; 4(2):ofx023. PubMed ID: 28730155 [TBL] [Abstract][Full Text] [Related]
34. Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge. Tully CM; Chinnakannan S; Mullarkey CE; Ulaszewska M; Ferrara F; Temperton N; Gilbert SC; Lambe T J Immunol; 2017 Jul; ():. PubMed ID: 28724579 [TBL] [Abstract][Full Text] [Related]
35. Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges. Coughlan L; Lambe T Vaccines (Basel); 2015 Apr; 3(2):293-319. PubMed ID: 26343189 [TBL] [Abstract][Full Text] [Related]
36. A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies. Bernelin-Cottet C; Deloizy C; Stanek O; Barc C; Bouguyon E; Urien C; Boulesteix O; Pezant J; Richard CA; Moudjou M; Da Costa B; Jouneau L; Chevalier C; Leclerc C; Sebo P; Bertho N; Schwartz-Cornil I Front Immunol; 2016; 7():641. PubMed ID: 28082980 [TBL] [Abstract][Full Text] [Related]
37. Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza Infection. Duan S; Thomas PG Front Immunol; 2016; 7():25. PubMed ID: 26904022 [TBL] [Abstract][Full Text] [Related]